Finance

Beta
Lists
300406:SHE
Beijing Strong Biotechnologies Inc
CN¥11.95
+2.22%
(+0.26) 1D
Jun 5, 3:04:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300406...
Open
CN¥11.72
High
CN¥12.05
Low
CN¥11.68
Mkt. cap
7.01B
Avg. vol.
5.82M
Volume
4.26M
Dividend
10.04%
Quarterly dividend
CN¥0.30
Ex-dividend date
May 29, 2026
P/E ratio
33.68
52-wk high
CN¥16.05
52-wk low
CN¥11.34
EPS
CN¥0.35
Shares outstanding
586.31M
No. of employees
998
Open
CN¥11.72
High
CN¥12.05
Low
CN¥11.68
Mkt. cap
7.01B
Avg. vol.
5.82M
Volume
4.26M
Dividend
10.04%
Quarterly dividend
CN¥0.30
Ex-dividend date
May 29, 2026
P/E ratio
33.68
52-wk high
CN¥16.05
52-wk low
CN¥11.34
EPS
CN¥0.35
Shares outstanding
586.31M
No. of employees
998
News stories
From sources across the web
About Beijing Strong Biotechnologies Inc
CEO-
Employees998
FoundedMar 29, 2001
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
348.53M
343.38M
343.79M
334.81M
Cost of goods sold
75.13M
67.34M
80.75M
60.47M
Cost of revenue
75.13M
67.34M
80.75M
60.47M
Research and development expenses
41.32M
43.47M
53.93M
40.55M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107.72M
105.98M
91.37M
100.28M
Operating expense
182.66M
137.43M
163.25M
146.16M
Total operating expenses
257.79M
204.77M
244.00M
206.63M
Operating income
90.74M
138.60M
99.80M
128.18M
Other non operating income
17.81M
-18.25M
615.35K
313.37K
EBT including unusual items
98.36M
110.58M
-70.71M
123.98M
EBT excluding unusual items
97.97M
110.27M
102.06M
120.91M
Income tax expense
6.22M
13.22M
11.82M
18.37M
Effective tax rate
6.32%
11.96%
-16.72%
14.82%
Other operating expenses
4.54M
5.27M
3.38M
5.33M
Net income
91.98M
97.23M
-82.59M
105.61M
Net profit margin
26.39%
28.31%
-24.02%
31.54%
Earnings per share
-
-
-
-
Interest and investment income
2.09M
1.51M
16.35M
4.86M
Interest expense
-11.88M
-12.37M
-13.25M
-12.44M
Net interest expenses
-9.79M
-10.87M
3.10M
-7.58M
Depreciation and amortization charges
-
-
-
-
EBITDA
107.81M
155.77M
116.77M
145.15M
Gain or loss from assets sale
749.60K
-749.60K
2.87M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more